SATB2 is constitutively expressed in the physiological colorectal mucosa and a majority of colorectal adenocarcinomas9–14 and is widely used as a routine immunohistochemical marker indicating a colorectal origin to differentiate colorectal adenocarcinomas from other adenocarcinoma primaries. This evidence concerns the gene SATB2 and adenocarcinoma.